Cardiac Oncology
Cardiac Oncology is the discipline that concentrates on the intersection of heart diseases and cancer. This field is growing at a faster rate because the survivors after cancer therapies are more prone to develop cardiovascular disease. The increase in cancer disease in the world has led to the emergence of numerous chemotherapeutic agents which are under preclinical or clinical studies. These agents are potent to cause damage to the heart (carddiotoxicity). Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or beta-blockers. The use of diagnostic imaging, noninvasive stress testing and ambulatory blood pressure monitoring and ambulatory cardiac telemetry can help to identify carddiotoxicity and lead to the development of preventative strategies.
- Cardiotoxic therapy
- Cardiac biomarkers
- Carddiotoxicity
- Cardiac tumors